Standard BioTools Inc. (NASDAQ:LAB) Q4 2022 Earnings Conference Call February 14, 2023 5:00 PM ET Company Participants Peter DeNardo - IR Michael Egholm - CEO and President Vikram Jog - CFO Conference Call Participants Operator Hello, and welcome to the Standard BioTools Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Peter DeNardo, Investor Relations. Thank you. Mr. DeNardo, you may beg ...

(1) Other revenue includes development, grant and license revenue Standard BioTools Reconciliation of GAAP to Non-GAAP Net Loss ITEMIZED RECONCILIATION BETWEEN GAAP AND NON-GAAP NET LOSS | --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------------|-------|---------------------------------------------------|-------|----------------|-------|-------------------------------------------------------|-------|-----------------| | $0 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _____________________________________________ Commission file number: 001-34180 STANDARD BIOTOOLS INC. (Exact na ...

Standard BioTools Inc. (NASDAQ:LAB) Q3 2022 Results Conference Call November 8, 2022 5:00 PM ET Company Participants Peter DeNardo - Investor Relations Michael Egholm - Chief Executive Officer and President Vikram Jog - Chief Financial Officer Operator Hello, and welcome to the Standard BioTools Inc. Third Quarter 2022 Financial Results Conference Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Peter DeNardo, Investor Relations. Thank you, Mr. DeNardo. Y ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _____________________________________________ Commission file number: 001-34180 STANDARD BIOTOOLS INC. (Exact name of ...

Unleashing tools to accelerate breakthroughs in human health SECOND QUARTER 2022 FINANCIAL RESULTS AUGUST 8, 2022 Standard BioTools Forward-looking statements L e g a l I n f o r m a t i o n This presentation and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding operational and strategic plans, revenue growth and business transformation expectations, potential acquisi ...

Standard BioTools Inc. (NASDAQ:LAB) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Peter DeNardo – Investor Relations Michael Egholm – Chief Executive Officer and President Vikram Jog – Chief Financial Officer Conference Call Participants Operator Hello, and welcome to the Standard BioTools Incorporated Second Quarter 2022 Financial Results Conference Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Peter DeNardo, Inve ...

| --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | REFINITIV STREETEVENTS EDITED TRANSCRIPT LAB.OQ - Q1 2022 Standard BioTools Inc Earnings Call EVENT DATE/TIME: MAY 05, 2022 / 9:00PM GMT | | | REFINITIV STREETEVENTS \| www.refinitiv.com \| Contact Us | | ©2022 Refinitiv. All rights reserved. Republication or redistribution of Refinitiv content, including by framing or similar means, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _____________________________________________ _____________________________________________ Securities registered pu ...

Standard Bitola Inc. (NASDAQ:LAB) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Peter DeNardo – Investor Relations Michael Egholm – Chief Executive Officer and President Vikram Jog – Chief Financial Officer Conference Call Participants Operator Greetings, and welcome to the Standard BioTools Inc. First Quarter 2022 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Peter DeN ...